Charles River Laboratories International Inc (CRL)
233.47
+3.58
(+1.56%)
USD |
NYSE |
May 03, 16:00
233.40
-0.06
(-0.03%)
After-Hours: 20:00
Charles River Laboratories International Cash from Investing (Quarterly): -238.37M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -238.37M |
| September 30, 2023 | -79.56M |
| June 30, 2023 | -76.61M |
| March 31, 2023 | -168.62M |
| December 31, 2022 | 44.38M |
| September 30, 2022 | -92.19M |
| June 30, 2022 | -462.11M |
| March 31, 2022 | -98.00M |
| December 31, 2021 | 9.307M |
| September 30, 2021 | -355.05M |
| June 30, 2021 | -954.19M |
| March 31, 2021 | -138.00M |
| December 31, 2020 | -88.42M |
| September 30, 2020 | -70.81M |
| June 30, 2020 | -28.63M |
| March 31, 2020 | -413.68M |
| December 31, 2019 | -70.87M |
| September 30, 2019 | -61.39M |
| June 30, 2019 | -528.42M |
| March 31, 2019 | -20.81M |
| December 31, 2018 | -70.96M |
| September 30, 2018 | -33.01M |
| June 30, 2018 | -826.37M |
| March 31, 2018 | -24.66M |
| December 31, 2017 | -32.83M |
| Date | Value |
|---|---|
| September 30, 2017 | -53.78M |
| June 30, 2017 | -38.97M |
| March 31, 2017 | 53.00M |
| December 31, 2016 | -75.00M |
| September 30, 2016 | -12.89M |
| June 30, 2016 | -598.33M |
| March 31, 2016 | -6.442M |
| December 31, 2015 | -78.64M |
| September 30, 2015 | -212.49M |
| June 30, 2015 | -24.20M |
| March 31, 2015 | -12.29M |
| December 31, 2014 | -80.80M |
| September 30, 2014 | -14.69M |
| June 30, 2014 | -195.99M |
| March 31, 2014 | -6.511M |
| December 31, 2013 | -19.71M |
| September 30, 2013 | -14.35M |
| June 30, 2013 | -11.20M |
| March 31, 2013 | -28.78M |
| December 31, 2012 | -19.77M |
| September 30, 2012 | -26.64M |
| June 30, 2012 | -5.30M |
| March 31, 2012 | -3.278M |
| December 31, 2011 | -24.60M |
| September 30, 2011 | -4.17M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-954.19M
Minimum
Jun 2021
44.38M
Maximum
Dec 2022
-203.75M
Average
-92.19M
Median
Sep 2022
Cash from Investing (Quarterly) Benchmarks
| Cardinal Health Inc | -1.847B |
| Stryker Corp | -408.00M |
| DaVita Inc | -215.21M |
| IDEXX Laboratories Inc | -106.94M |
| Medpace Holdings Inc | 2.53M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 220.94M |
| Cash from Financing (Quarterly) | 123.57M |
| Free Cash Flow | 365.37M |
| Free Cash Flow Per Share (Quarterly) | 2.779 |
| Free Cash Flow to Equity (Quarterly) | 9.69M |
| Free Cash Flow to Firm (Quarterly) | 171.55M |
| Free Cash Flow Yield | 3.04% |